Stocks / TNDM / Free Cash Flow

Tandem Diabetes Care, Inc. Free Cash Flow 2012–2025

Tandem Diabetes Care, Inc. reported $-29.67M of free cash flow for fiscal 2025. That was 694.1% lower than fiscal 2024. Compared with fiscal 2020, the change was -983.2%.

Latest filed value
$-29.67M
One-year change
-694.1%
Change since 2020
-983.2%
Latest period end
2025
Tandem Diabetes Care, Inc. Free Cash Flow history from 2012 to 2025FY 2012: -38000000FY 2013: -51767000FY 2014: -65784000FY 2015: -64528000FY 2016: -70103000FY 2017: -71854000FY 2018: -11305000FY 2019: 22365000FY 2020: -2739000FY 2021: 97179000FY 2022: 16367000FY 2023: -58614000FY 2024: 4994000FY 2025: -29669000
Annual filed history. Hover chart points for raw values; the accessible table below is the source of record.
Fiscal yearFree Cash FlowChange (YoY)
FY 2025$-29.67M-694.1%
FY 2024$4.99M+108.5%
FY 2023$-58.61M-458.1%
FY 2022$16.37M-83.2%
FY 2021$97.18M+3648.0%
FY 2020$-2.74M-112.2%
FY 2019$22.36M+297.8%
FY 2018$-11.30M+84.3%
FY 2017$-71.85M-2.5%
FY 2016$-70.10M-8.6%
FY 2015$-64.53M+1.9%
FY 2014$-65.78M-27.1%
FY 2013$-51.77M-36.2%
FY 2012$-38.00M

Source: Tandem Diabetes Care, Inc. SEC filings — cash flow statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open TNDM 10-K filings at SEC EDGAR · Methodology · Download CSV.

How to read this history

Tandem Diabetes Care, Inc. reported $-29.67M of free cash flow for fiscal 2025. That was 694.1% lower than fiscal 2024. Compared with fiscal 2020, the change was -983.2%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.

Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.

See the full picture for Tandem Diabetes Care, Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

Tandem Diabetes Care, Inc. — frequently asked questions

What is Tandem Diabetes Care, Inc.'s free cash flow?

Tandem Diabetes Care, Inc. (TNDM) reported free cash flow of $-29.67M for fiscal year 2025, per its SEC filings.

Where does this data come from?

Figures are computed from Tandem Diabetes Care, Inc.'s official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.

More TNDM financial history

Full TNDM fundamentals page → · Analyze free cash flow with a free tool → · All 1,500+ companies →